These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30412988)

  • 21. Safety issues associated with using medication to treat overactive bladder.
    Araklitis G; Cardozo L
    Expert Opin Drug Saf; 2017 Nov; 16(11):1273-1280. PubMed ID: 28889761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials.
    Cao Y; Lv J; Zhao C; Li J; Leng J
    Clin Drug Investig; 2016 Oct; 36(10):801-8. PubMed ID: 27384416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial Comment: Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study.
    Moreno-Palacios J
    Int Braz J Urol; 2021; 47(4):890-891. PubMed ID: 33848083
    [No Abstract]   [Full Text] [Related]  

  • 24. Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome.
    Rahman SN; Monaghan TF; Weiss JP
    Obstet Gynecol; 2020 Feb; 135(2):483. PubMed ID: 31977788
    [No Abstract]   [Full Text] [Related]  

  • 25. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
    Staskin DR
    Urol Clin North Am; 2006 Nov; 33(4):465-73, viii. PubMed ID: 17011382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic therapy: do the patients take the pills prescribed?
    Jundt K; Schreyer K; Friese K; Peschers U
    Arch Gynecol Obstet; 2011 Sep; 284(3):663-6. PubMed ID: 21046135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Using autonomous electrostimulation device Erektron in treating female overactive bladder].
    Yarin GY; Shelyakina OV; Fedorenko VN; Alekseeva AV; Vilgelmi IA
    Urologiia; 2016 Nov; (5):43-46. PubMed ID: 28248019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
    Nordling J
    Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and tolerability of anticholinergics in Korean children with overactive bladder: a multicenter retrospective study.
    Park SJ; Pai KS; Kim JM; Park K; Kim KS; Song SH; Park S; Kim SO; Ryu DS; Baek M; Lee SD; Lee JW; Im YJ; Han SW; Chung JM; Cho MH; Ha TS; Cho WY; Suh HJ;
    J Korean Med Sci; 2014 Nov; 29(11):1550-4. PubMed ID: 25408588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in the Pharmacological Management of Nursing Home Residents with Overactive Bladder or Urinary Incontinence.
    Zarowitz BJ; Allen C; O'Shea T; Tangalos EG; Berner T; Ouslander JG
    J Am Geriatr Soc; 2015 Nov; 63(11):2298-307. PubMed ID: 26503458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Potential of Human Chorionic Gonadotropin Against Overactive Bladder.
    Rao CV
    Reprod Sci; 2016 Sep; 23(9):1122-8. PubMed ID: 26546803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.
    Madhuvrata P; Singh M; Hasafa Z; Abdel-Fattah M
    Eur Urol; 2012 Nov; 62(5):816-30. PubMed ID: 22397851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
    Di Marco J; De Broglie C; Manceau P; Weglinski L; Le Breton F; Verrollet D; Amarenco G
    Prog Urol; 2016 Mar; 26(4):226-9. PubMed ID: 26826771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravesical treatment of overactive bladder syndrome].
    Haferkamp A; Hohenfellner M
    Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current management of overactive bladder.
    Cartwright R; Renganathan A; Cardozo L
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):489-95. PubMed ID: 18797274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticholinergic Drugs for Overactive Bladder in Frail Older Patients: The Case Against.
    Woodford HJ
    Drugs Aging; 2018 Sep; 35(9):773-776. PubMed ID: 30097908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder.
    Shepherd JP; Carter-Brooks CM; Chermanksy C
    Int Urogynecol J; 2018 Aug; 29(8):1213-1219. PubMed ID: 29671033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic therapy for overactive bladder: a nicotinic modality?
    Toler SM; Yohannes D; Lippiello PM; Chancellor MB
    Med Hypotheses; 2013 Sep; 81(3):456-8. PubMed ID: 23834857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic prescription: are healthcare professionals the real burden?
    Araklitis G; Thiagamoorthy G; Hunter J; Rantell A; Robinson D; Cardozo L
    Int Urogynecol J; 2017 Aug; 28(8):1249-1256. PubMed ID: 28091711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.